What is it about?
Antibiofilm action of ZnO, SnO2 and CeO2 nanoparticles towards Gram-positive biofilm forming pathogenic bacteria such as Listeria monocytogenes and Staphylococcus aureus.
Featured Image
Why is it important?
Results have shown that ZnO, SnO2 and CeO2 NPs effectively inhibited biofilm formation of both L. monocytogenes and S. aureus. Microscopic analysis also confirmed the antibiofilm activity of these NPs. In addition, ZnO NPs inhibited the cell growth as well as the production of amyloid protein in S. aureus. Overall, these results indicated that ZnO, SnO2 and CeO2 NPs can be considered as potential agents for treating the infections caused by L. monocytogenes and S. aureus, especially those associates with the bacterial biofilm formation. In addition, since this is the first study to report about these effects for ZnO, SnO2 and CeO2 NPs, further studies are required in order to understand their mechanisms at both phenotypic and molecular levels, as well as their in vivo cytotoxicity, thereby enabling the applications of these metal oxide NPs in biomedical fields and food industry.
Perspectives
Read the Original
This page is a summary of: Antibiofilm Action of ZnO, SnO2 and CeO2 Nanoparticles Towards Grampositive Biofilm Forming Pathogenic Bacteria, Recent Patents on Nanotechnology, October 2020, Bentham Science Publishers,
DOI: 10.2174/1872210514666200313121953.
You can read the full text:
Resources
Contributors
The following have contributed to this page